Bala Attili Selected Research

2- (4- (3- quinolin- 6- ylmethyl- 3H- (1,2,3)triazolo(4,5- b)pyrazin- 5- yl)pyrazol- 1- yl)ethanol

1/2021

Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bala Attili Research Topics

Disease

4	Neoplasms (Cancer) 08/2021 - 12/2020
2	Neuroinflammatory Diseases 01/2020 - 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	medullary Thyroid cancer 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2019

Drug/Important Bio-Agent (IBA)

1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	cabozantinibIBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	RadiopharmaceuticalsIBA 01/2021
1	Proto-Oncogene Proteins c-metIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	Cell Surface ReceptorsIBA 01/2021
1	2- (4- (3- quinolin- 6- ylmethyl- 3H- (1,2,3)triazolo(4,5- b)pyrazin- 5- yl)pyrazol- 1- yl)ethanolIBA 01/2021
1	PhosphatidylserinesIBA 12/2020
1	Carrier Proteins (Binding Protein)IBA 12/2020
1	Synaptotagmin IIBA 12/2020
1	Purinergic P2X7 ReceptorsIBA 01/2020
1	CannabinoidsIBA 01/2019
1	STA 9090IBA 01/2019
1	6- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA 01/2019

Therapy/Procedure

2	Therapeutics 01/2021 - 12/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2021
1	Drug Therapy (Chemotherapy) 12/2020